PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-97.35%
Negative net income growth while CRWD stands at 30.05%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
16.77%
D&A growth well above CRWD's 6.21%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-592.24%
Negative yoy deferred tax while CRWD stands at 61.99%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
1.99%
Slight usage while CRWD is negative at -200.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.99%
Lower 'other working capital' growth vs. CRWD's 100.00%. David Dodd would see fewer unexpected short-term demands on cash.
11744.12%
Well above CRWD's 14.15%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-10.84%
Both yoy CFO lines are negative, with CRWD at -13.35%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-21.97%
Negative yoy CapEx while CRWD is 64.44%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
30.27%
Purchases well above CRWD's 31.64%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-31.91%
Both yoy lines are negative, with CRWD at -36.63%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
No Data
No Data available this quarter, please select a different quarter.
9.74%
Lower net investing outflow yoy vs. CRWD's 52.10%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
32.24%
We slightly raise equity while CRWD is negative at -200.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-106.83%
We cut yoy buybacks while CRWD is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.